Effects of Wellnara on Climacteric Symptoms

CompletedOBSERVATIONAL
Enrollment

749

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Postmenopause
Interventions
DRUG

E2/LNG oral (Wellnara, BAY86-5029)

Patients in daily life treatment receiving Wellnara according to local drug information.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY